FDA accepts ORPH's Xyrem response

Orphan Medical (ORPH) said the FDA accepted the company's plan to address issues raised by the agency in its July 2 approvable letter for ORPH's Xyrem to treat narcolepsy (see BioCentury, July 23). O...